Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SR Medical Technology CoGRLIF 43 5-Year Yield-on-Cost % is 0.00 as of Sep. 05, 2026. GuruFocus rates GRLIF with a GF Score™ of 43/100. The stock has 6 warning signs investors should review. Among 854 Real Estate companies, SR Medical Technology Co ranks worse than 117095.9% on this metric.
The historical rank and industry rank for SR Medical Technology Co's 5-Year Yield-on-Cost % or its related term are showing as below:
GRLIF's 5-Year Yield-on-Cost % is not ranked *
in the Real Estate industry.
Industry Median: 3.81 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
SR Medical Technology Co (OTCPK:GRLIF) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
SR Medical Technology Co 5-Year Yield-on-Cost % Related Terms
GRLIF vs CBRE, BEKE, JLL: 5-Year Yield-on-Cost % Comparison
For the Real Estate Services subindustry, SR Medical Technology Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SR Medical Technology Co 5-Year Yield-on-Cost % vs Real Estate Industry
For the Real Estate industry and Real Estate sector, SR Medical Technology Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where SR Medical Technology Co's 5-Year Yield-on-Cost % falls into.
SR Medical Technology Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
SR Medical Technology Co (GRLIF) has a 5-Year Yield-on-Cost % of 0.00 as of Sep. 05, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on SR Medical Technology Co and its competitors. According to the industry distribution chart, SR Medical Technology Co ranks #999999 out of 854 companies in the Real Estate industry.
Is SR Medical Technology Co's 5-Year Yield-on-Cost % too high?
SR Medical Technology Co's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, SR Medical Technology Co ranks #999999 out of 854 companies in the Real Estate industry, which is in the bottom quartile relative to peers. Overall, SR Medical Technology Co has a GF Score™ of 43/100, reflecting its overall financial health beyond just this single metric.
How does SR Medical Technology Co's 5-Year Yield-on-Cost % compare to CBRE and BEKE?
According to the Real Estate industry distribution chart, SR Medical Technology Co ranks #999999 out of 854 companies for 5-Year Yield-on-Cost %. This places SR Medical Technology Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Real Estate company?
The median 5-Year Yield-on-Cost % among Real Estate companies is 3.81, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on SR Medical Technology Co and its competitors. For the Real Estate industry, the median 5-Year Yield-on-Cost % is 3.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SR Medical Technology Co's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SR Medical Technology Co stock overvalued right now?
SR Medical Technology Co (GRLIF) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. SR Medical Technology Co's overall GF Score™ is 43/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For SR Medical Technology Co (GRLIF), the current 5-Year Yield-on-Cost % is 0.00 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
GR Life Style Co Ltd is an investment holding company. The Group is principally engaged in the property development and investments in the PRC, the USA and the UK, and the provision of property management services in the PRC. The Group has two reportable operating segments: the property development and investment segment, which engages in property development and investment in the UK, the USA and Chinese Mainland; and the property management segment, which engages in the provision of property management and other services for office buildings, residential properties and car parks in Chinese Mainland. The Group operates in Chinese Mainland with maximum revenue, the UK, and the USA.
43GF Score
Get the complete analysis for GRLIF
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRLIF has been successfully added to your 
